Innovating Works

S4DX

Financiado
The world s first digital data fingerprint for human blood samples.
"Smart4Diagnostics (S4DX) has developed the world’s first digital human sample data-fingerprint for human blood samples in pre-preanalytics. We aks for EIC-support to catapult this innovation into a market-changing product. S4DX... "Smart4Diagnostics (S4DX) has developed the world’s first digital human sample data-fingerprint for human blood samples in pre-preanalytics. We aks for EIC-support to catapult this innovation into a market-changing product. S4DX detects and reduces pre-preanalytical errors at sample collection when patients are still present. This is a quantum leap in quality and safety for patients, doctors and laboratories. They receive reliable results and painful re-visits and re-collection of samples are avoided. With our innovation we change medical diagnostics from ""trust-based to evidence-based. We provide a complete dataset on the quality of each human sample from blood draw until analysis. Our solution provides the new pre-preanalytical data-standard for sensitive medical diagnostics in the future. S4DX digital human sample fingerprint will be the necessary data-baseline for highly sensitive tests (e.g. liquid biopsy). Market-entry in Europe with our MVP is planned for Dec. 2020. Our data will be used to refine our pattern-recognition algorithms and thus provide the basis for personalized and precision diagnostics. We collaborate with leading international partners. Roche Diagnostics and Sarstedt are technical advisors, leading European lab chains (Bioscientia/Germany, Medisupport/Switzerland and Certe/ Netherlands) are implementation partners; Würth Electronics provides access to manufacturers and supply chain partners. The company was founded in Jan. 2018, won the EIT-Health Wildcard as best eHealth start-up in Europe, the Hackathon of the TU Munich/Germany as best start-up and was chosen globally by the WHO as one of ten most promising start-ups in 2018. In April 2019 the Investment committee of the High-Tech-Gründerfonds voted unanimously to accept S4DX for further investment of 1 Mio. €, in July 2019 ACI/ Boston accepted us as one of six companies globally in the Gold-Track-Program for massive global scaling in healthcare. " ver más
30/09/2021
S4DX
1M€
Duración del proyecto: 18 meses Fecha Inicio: 2020-03-09
Fecha Fin: 2021-09-30

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2021-09-30
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020: SME instrument
Cerrada hace 6 años
Presupuesto El presupuesto total del proyecto asciende a 1M€
Líder del proyecto
SMART4DIAGNOSTICS GMBH No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5